Close Window Close Window
CAR-T Congress
Boston, MA
16/04/2019 - 17/04/2019
URL:   Click here for the event website.
Organizer:   Kisaco Research
Description:
CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.
The fourth annual CAR-T congress USA is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy.
With two tracks for preclinical discovery and clinical development, refine your methods from optimizing T cell phenotypes and longevity to providing quality control for robust manufacturing. With sessions ran by Gilead and Legend Biotech on strengthening the business strategy for CAR-T and global regulation sessions ran by the EMA, this is your chance to be informed when commercialising your CAR-T therapy.
Close Window